GT Biopharma Inc (GTBP)

GT Biopharma Inc (GTBP) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $14.5M; returns 1 day -1.1%, 1 week -22.3%.

GT Biopharma, Inc. (NASDAQ: GTBP) is a clinical-stage biopharmaceutical company focused on developing and commercializing immuno-oncology therapeutic products based on their proprietary TriKE® (Tri-specific Killer Engager) NK cell engager platform. The TriKE platform harnesses natural killer (NK) cells to target and attack cancer.

Groups GTBP belongs to

• Biotechnology
• Biopharmaceutical
• Recent Reverse Splits
• Clinical Stage
• Oncology
• Cancer Therapeutics
• Immunotherapy
• Healthcare
• Clinical Stage Biotech
• Clinical Stage Biopharma
• Life Sciences
• Hematologic Malignancies
• Hematology
• Biologics
• Antibody Therapeutics

GTBP financial model: income statement, cash flow and balance sheet